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The Internet has become a common and global medium. It contains vast information
resources and a wide range of communication instruments. One of the communication
channels are social media, which increasingly are also used in the business field.
Social media combined with mobile technology introduced new challenges to marketing
activity. This trend is also observed on specific and highly regulated drug market.
The aim of this article is to describe the perspectives for the use of social media in
e-pharmamarketing. We find that this require personalized communication, the use of
online promotion tools, in order to perform advertising in contact with a demanding
client. Currently pharmaceutical companies use social media to communicate basic
information on their life, but they still do not appreciate it sufficiently as a tool to build the
image of company or products. It is therefore considered that these companies should
attach greater importance to the presence in this type of media, especially in the light of
dynamic changes in the way people communicate.
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INTRODUCTION
The Internet has revolutionized the world and is growing rapidly, the same as possibilities of
using it in the functioning of society and business. Better access to the global network increases
the number of users [46% of world population – 3,42 billion people (Blog smmeasure. Liczby
Polskiego Internetu, 2016)]. The traditional media are being replaced by the Internet to some
extent, because of its accessibility: convenient time of information releases and the possibility
of selecting interesting news by the recipient. One of the online media is social media, which is
currently used by 2.31 billion people in the world (Mobirank, 2016), including 1.97 billion (27%
of the world’s population) using mobile devices. (Mobirank, 2016). Their main advantage is the
interactivity and two-way flow of information (Syrkiewicz-S´witała and S´witała, 2012).
Since the introduction of e-mail, new media (e.g., YouTube) and social networking (e.g.,
Facebook, and Twitter) the ways of human communication have changed noticeable. These
changes are observed regardless of the age of Internet users. This is obviously more popular among
the younger generation but it is used increasingly among the elderly as well (Syrkiewicz-S´witała,
2015b). Popular nowadays social media, which were meant only to maintain ties and relationships,
has also become a place to promote and strengthen the image of companies (Chaudhry, 2011;
Gibson, 2012; Królewski and Sala, 2014). They have created a new paradigm of communication,
which is based on web surfers’ activity. Internet users make and distribute Internet transmission,
they become even prosumers (Pikuła-Małachowska, 2010; Syrkiewicz-S´witała, 2014). These new
media outdated existing action scheme in marketing. In last 5 years, the importance of social
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media has increased significantly, and market activities in this
area are the fastest growing sector of Internet marketing. Social
media become finally also a source of health information (Evans,
2006; Bernhardt et al., 2014; Syrkiewicz-S´witała and S´witała,
2015). In recent years, Facebook has become one of the most
popular sources of information on health in the UK (Collier,
2014; Syrkiewicz-S´witała, 2015a).
The use of modern technology in the pharmaceutical market
is not only the implementation of modern production techniques
and supply of consumers with innovative medicinal products.
The dynamic development of interactive electronic media
of a social network gives also a huge field of possibilities
for the use of innovative methods of selling and building
market position of companies operating in the pharmaceutical
industry. Thus is created e-pharmamarketing. It is an activity
of a pharmaceutical company aimed to promote and sell its
products and build a relationship with the customer or selected
groups of recipients, conducted via the Internet (Armstrong
and Kotler, 2012). The purpose of this article is to describe
the prospects for the use of e-pharmamarketing via social
media.
THE EXPERIENCE OF
PHARMACEUTICAL COMPANIES IN
SOCIAL MEDIA MARKETING
Marketing of pharmaceutical companies in social media can rely
on generating Internet traffic by the use of social networking
sites. It enables direct contact with a target group, also reducing
marketing costs. It aims at formation of relationship between
a pharmaceutical company and doctors or patients. This is not
a method to achieve rapid sales growth, but it is to become a
partner for dialog. The goal is to influence positive image of
a company and, at the same time, to encourage customers to
share information with friends. Social media marketing relies
on effective fanpage management of a brand or a company.
This is public relations and marketing operation. Pharmaceutical
companies may place counseling articles on social networking
sites. The topics may cover health, medicine, lifestyle, nutrition,
etc. Photos, videos, commercials, and short text messages can be
also published.
The authors of this article conducted a survey on 50 biggest
pharmaceutical companies operating in Poland (Pharmaceutical
Representative luty-marzec 2014/nr1(31) TOP 50, 2016). The
obtained results showed that the vast majority of pharmaceutical
companies (86% of companies surveyed) has an account on a
social networking site. The most popular services were: Facebook
(76% of responses), Twitter (34%), LinkedIn (32%) and Google+
(12%). These are also the most popular portals globally. Facebook
unites 1.59 billion users worldwide (Blog smmeasure. Liczby
Polskiego Internetu, 2016), Twitter 320 million users (Blog
smmeasure. Liczby Polskiego Internetu, 2016), LinkedIn has a
base of 100 million people (Blog smmeasure. Liczby Polskiego
Internetu, 2016), and Google+ although is the youngest (opened
in 2011) was able to convince already 1 billion Internet users
(Grabiec, 2016).
A vast majority of pharmaceutical companies benefit from
the YouTube platform as well. YT has already over 1 billion
users in the world (YouTube Statystyki, 2016). 70% of surveyed
companies provide audiovisual messages in this way, but
only 32% of them declare the use of YT for advertising
purposes. This may be due to legal restrictions on advertising
of medicines in different countries. The companies use YT to
present their functioning (company events, charitable activities,
drug manufacturing process and other information that can
positively affect the company’s image). Thanks the dynamic
ability to distribute similar types of materials in social networks,
companies gain maximum reach and brand visibility. It is done
with a relatively small outlay of work by PR and marketing
professionals.
Video marketing and discussion forums are much less used.
Blogging is not popular. None of companies used chat. While
social networking, the companies: provide information reference
(56%), try to build the company image (54%), communicate
professional staff and consumer (28%). 26% of surveyed
companies want to increase sales of their products. Only few of
them (8%) use social media to strengthen brand awareness.
Unfortunately, microblogs are still less popular than social
networking among pharmaceutical companies. Microblogs
provide the opportunity for pharmaceutical companies to submit
short entries, slogan, logo, links to other reference sites or articles.
Microblog’s entries are only to encouraged to click on a link and
read full content on a website or enter into a discussion. The
companies often indicate briefly on a received award, sponsored
events, study on a new product, a new drug registration and
others.
PERSPECTIVES FOR THE USE OF
E-PHARMAMARKETING CARRIED OUT
THROUGH SOCIAL MEDIA
E-pharmamarketing in social media is not without disadvantages.
Among the most important are the lack of immediate results
and difficult measurability. It is because similar types of
activities are carried out in an integrated promotional
activities of pharmaceutical companies (Düssel, 2009;
Heuristic, 2016). It is also a time-consuming form which
requires regularity, driving continual dialog, permanent
relationships maintaining and involvement (Heuristic,
2016). This form is insufficient in developing countries,
where the problem of digital exclusion is widespread. Even
among EU member states this is not completely abstract
problems. In Romania less than 50% of the population use
the Internet (Wykluczenie cyfrowe w Polsce. Raport grudzieñ,
2015).
Not without significance is the lack of full acceptance of
social media. There is relatively low confidence in the network
and the Internet users dislike impudence (spam; Hamala, 2014;
Heuristic, 2016). The overabundance of information available
on the Internet raises the noise effect in communication and
searching for true and accurate content (Syrkiewicz-S´witała and
S´witała, 2012). No full control over the flow of information
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provides the risk of unauthorized content, as well as an unethical
actions – information fraud, falsification of identity or privacy
violation (Hamala, 2014; Heuristic, 2016).
A significant difficulty is in final subordination of distributed
content to legal and ethical requirements in different countries
and cultures, which reduces the possibility of full universalization
of globally distributed content.
Nevertheless, there are a lot of potential benefits: high
interactivity, knowing competition and customer expectations
(Syrkiewicz-S´witała and S´witała, 2015), possibility of far-
reaching personalization of media and communication (Nowy
Marketing, 2015b; Raport IRCenter.com styczeñ, 2016),
expanding the availability of online communication channels
(Google Trends, 2016), high dynamic of communication spread
(Nowy Marketing, 2015b) and possibility of building a positive
company image (Szydłowska, 2013; RAPORT, 2016). In the light
of the observable trends it is simply necessary to maintain a
competitive position in the market.
The potential of social media, however, still seems to
be overlooked by pharmaceutical companies (Ustawa, 2001;
Niedzielska and Syrkiewicz-S´witała, 2011; Syrkiewicz-S´witała
et al., 2015). Many companies neglect important aspects of
the use of tools such as e.g., ability to know the expectations
of customers, as well as free publicity (n = 2; 4%) and the
ability to control competition. As burdensome is perceived the
need to constantly monitor the content or possibility of losing
the positive company image, as well as lack of control over
the content being placed. As a result, companies operating in
the pharmaceutical industry tend to remain at least one step
behind the technological progress in the field of communication
tools, losing the ability to generate available benefits. One
example of this may be Polish pharmacies. According to
conducted monitoring in social media by the Institute of Media
Monitoring (IMM) in the first half of 2016 only 20% requests
for pharmacy recommendation received answers within the
first 36 h after publication. So 80% of pharmacies lost the
possibility of contact with the client in the network (Marketing,
2016). Companies do not appreciate the potential of specialized
portals such as GoldenLine, which is the local equivalent of
LinkedIn, visited by almost 2 million Internet users in Poland
(Wirtualnemedia.pl., 2016). Potentially, this is a very useful
tool in the process of the recruitment of skilled workers
(Kowalczyk, 2012; Profil firmy Adamed na portalu LinkedIn,
2016).
It is expected to boost the activity of companies in this
field. It is inevitable for the substantial development of modern
mobile technologies, which directly translates to the popularity
of social media. However, one can expect the change of interest
of Internet users in specific digital medium. Perhaps, instead
of popular Facebook there will be some other medium more
attractive for customers. Therefore, it is important to monitor
constantly the activities of Internet users in social media and on
specific portals. Technological progress creates new marketing
opportunities for pharmaceutical companies. It also forces to
follow new trends, or their creation. Companies need to take
creative and innovative approach and to act beyond tamed
schemes.
CONCLUSION
Skillfully lead social media pharmamarketing can help
build a good relationship with the client on a specific and
highly regulated pharmaceutical market. It can be helpful in
communicating all necessary information about pharmaceutical
products but also promote pro-health actions in the field of
promotion and prevention (Akhtar et al., 2015). Social media
marketing of pharmaceutical companies is therefore a growing
area with great potential. This development is also supported by
certain organizational measures on the drug market (Holecki
et al., 2013). In November 2015, American Food and Drug
Administration (FDA) has encouraged the use of social media
to improve communication and information exchange in
health promotion and public health (U.S. Food and Drug
Administration Social Media Policy, 2015). Foreign studies show
that one in four interactions with doctor, patient, and healthcare
provider in the United States is a digital contact (Social media
in the pharmaceutical sector. UK Synapse, 2013). Patient
education through social media is therefore an opportunity for
the pharmaceutical industry to gain confidence in the company
and increase the awareness of consumer when choosing a
product. In this way, customer acquires knowledge about health,
diseases, and treatment. In various social media channels it is
possible to find information on any drug. This information is
available on: websites of a manufacturer, social network brand
fanpages, portals for white staff specialists. According to a study,
conducted by Comscore, patients who are familiar with drug
brand website often followed the recommendations for its use
(20% of patients). Internet advertising also influenced the use of a
drug (13.5% of patients; ROI Media, 2016). E-pharmamarketing
activities in social media and in the network tend to increase. It is
estimated that in the year 2016 the US pharmaceutical companies
allocate for this purpose 2.48 billion dollars (Berezowski, 2015).
Media house Codemedia reported that spending on advertising
in Poland on the Internet reaches 7%, i.e., more than 17 million
PLN (year 2015) and it increased by 68%, as compared to the
previous year (Nowy Marketing, 2015a).
Having a website is no longer a novelty by pharmaceutical
companies, but actions in social media are innovative. It is still
a very demanding area, obliging a good knowledge of the medical
community and the needs of patients, as well as the compliance of
pharmaceutical law in force in a country. All information on the
websites of drug manufacturers is assessed by regulatory agencies
in terms of their compliance with the pharmaceutical law.
Therefore, besides the promotion of a brand itself, much of the
information applies to illnesses, possible treatments, preventions,
health information and healthy lifestyles (Bell et al., 2014). By
placing the counseling health related topics, the public awareness
increases. Thus positive recommendations among Internet users
translate into sales (Akhtar et al., 2015). Every advertising or
educational campaign carried out in social media must be very
well thought out. It requires also constant monitoring of various
social media. It should be also noted that the conduct of strategy
in social media cannot be standardized, despite the fact that
most companies have a global reach. It is to mention that
widespread use of social media is very similar in all markets
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but the reactions of people belonging to different cultures are
very different. Therefore, companies in this marketing strategy
in social media should use adaptive approach i.e., the content and
form of communication must comply with the specifics culture
of the community. Then that action in this field will be more
effective. Involvement in social media will help to build a positive
relationship oriented to the needs of a particular client.
Activities in social media may be helpful also in emergency
situations. They may assist in all situations such as: pollution in
batches of the drug or an incorrect description on the packaging.
In such situation it is important to reach a wide audience quickly
and effectively. Social media can supplement the instruments
used in effective crisis management. They can be used as a source
of transmission of reliable and proven information to prevent
dissemination of adverse scheme: no information – guess –
rumors. Conducting marketing strategies of pharmaceutical
companies through social media has also a social significance.
It is also possible to use social media in emergency situations
i.e., natural disasters (floods, earthquakes, etc.). Most of the large
pharmaceutical companies, operating on corporate principles,
are involved yet in corporate social responsibility (CSR) and
for this purpose they reserve certain budgetary measures. By
communicating via social media, companies can rapidly engage
the local community for various rescue operations, supporting
them financially and materially. Through such activities they gain
synergy and their aid is effective and not anonymous. Therefore,
companies can expect positive effects in the dimension of public
relations.
Pharmaceutical companies can achieve many different goals
through the use of social media. They can improve the level of
knowledge; build relationships; increase sales of its own products
and finally serve general social purposes. As they seem not to
take the possible advantages arising of e-pharmamarketing yet, it
should be recommended they clearly re-orientate their marketing
activity toward new instruments of communication available via
Internet to stay up to date with the dynamic changes appearing in
the social life and communication channels.
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